ABSI vs VRTX · rev $533.0K vs P/E 30, rev $3.33B
Absci Corp (ABSI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Absci Corp (ABSI) is a biotechnology company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
Latest reported ABSI revenue for 2026-06-30 was $533.0K. Net income was -$62.8M. ABSI currently screens at market cap $1.13B.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ABSI currently screens at market cap $1.13B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ABSI and VRTX stock pages for the full models.
Not investment advice.